Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

The Dynamic Landscape of Age-Related Macular Degeneration and Diabetic Macular Edema: Real-World Evidence (Live Webinar)

This educational activity is sponsored by Postgraduate Healthcare Education, LLC (PHE) and supported by an educational grant from Genentech.

Registration & Dates for Activities

Wednesday, June 29, 2022
7:30 – 9:00 PM ET

Faculty

Sheldon J. Rich, RPh, PhD
Adjunct Assistant Professor
University of Michigan College of Pharmacy
Ann Arbor, MI President
SJR Associates, LLC
Sarasota, FL

John W. Kitchens, MD
Ophthalmologist, Vitreoretinal Surgeon &
Partner Retina Associates of Kentucky
Voluntary Faculty
University of Kentucky
Lexington, KY

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-0000-22-048-L01-P
Credits: 1.5 hours (0.15 ceu)
Estimated time to complete activity: 90 minutes

Location: From the convenience of your home or business; accessible via both PC and MAC
Fee Information: There is no fee for this educational activity.
Type of Activity: Application
Media: Internet

TARGET AUDIENCE

Managed care and specialty Pharmacists

HOW TO EARN CREDIT

Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live webinar; and 3) complete the evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor.

Goal

The goal of these educational activities is to provide managed care and specialty pharmacists with advanced and up-to-date knowledge of the evolving AMD and DME treatment landscape as well as the importance of RWE to guide treatment decision making to optimize patient care and improve outcomes and quality of life for patients with these conditions.

LEARNING OBJECTIVES

Upon completion of this activity, the participant should be better able to:

• Describe age-related macular degeneration (AMD) and diabetic macular edema (DME) and their impact on patient quality of life
• Discuss current and emerging treatment options for AMD and DME, including efficacy, safety, and relevant clinical trial data
• Interpret the rationale for using real-world evidence in treatment decision making for AMD and DME to optimize patient quality of life and outcomes
• Recognize approaches to assist in improving outcomes in AME and DME

Agenda

Introduction (5 minutes)
Presentation (75 minutes)
Conclusions & Question & Answer Session (10 minutes)

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5